Serina Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2016 | — | $-22.4M | $259.0K |
| Dec 2017 | — | $7.3M | $7.4M |
| Mar 2018 | — | $9.0M | $8.5M |
| Jun 2018 | — | $12.2M | — |
| Sep 2018 | — | $10.7M | — |
| Dec 2018 | — | $7.4M | $6.7M |
| Mar 2019 | — | $9.3M | $8.6M |
| Jun 2019 | — | $6.7M | $5.8M |
| Sep 2019 | — | $4.3M | $3.8M |
| Dec 2019 | — | $2.2M | $2.4M |
| Mar 2020 | — | $-739.0K | $468.0K |
| Jun 2020 | — | $-2.4M | $1.0M |
| Sep 2020 | — | $-3.7M | $1.1M |
| Dec 2020 | — | $-5.1M | $527.0K |
| Mar 2021 | — | $-6.1M | $809.0K |
| Jun 2021 | — | $-8.3M | $615.0K |
| Sep 2021 | — | $-9.9M | $731.0K |
| Dec 2021 | $13.2M | $-11.8M | $584.0K |
| Mar 2022 | — | $-11.5M | $448.0K |
| Jun 2022 | — | $-13.2M | $702.0K |
| Sep 2022 | $15.6M | $-15.1M | $466.0K |
| Dec 2022 | $18.1M | $-37.8M | $645.0K |
| Mar 2023 | — | $-36.1M | $280.0K |
| Jun 2023 | — | $-22.2M | $261.0K |
| Sep 2023 | — | $-27.5M | $397.0K |
| Dec 2023 | — | $-32.3M | $7.6M |
| Mar 2024 | — | $-4.3M | $8.7M |
| Jun 2024 | — | $-16.4M | $6.1M |
| Sep 2024 | $11.2M | $-13.8M | $3.2M |
| Dec 2024 | — | $641.0K | $3.7M |
| Mar 2025 | — | $1.7M | $4.3M |
| Jun 2025 | — | $1.8M | $6.0M |
| Sep 2025 | — | $1.8M | $8.6M |
| Dec 2025 | — | $-37.0K | $3.1M |
| Mar 2026 | — | $17.6M | $24.5M |
| Jun 2026 | — | $18.7M | $23.0M |